CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $202,000 | -99.5% | 5,971 | -99.6% | 0.00% | -100.0% |
| Q1 2021 | $37,215,000 | +10.1% | 1,591,061 | +35.6% | 0.04% | 0.0% |
| Q4 2020 | $33,790,000 | +69.4% | 1,173,248 | +19.2% | 0.04% | +46.2% |
| Q3 2020 | $19,944,000 | -13.1% | 984,422 | +28.9% | 0.03% | -16.1% |
| Q2 2020 | $22,947,000 | -44.2% | 763,608 | -41.6% | 0.03% | -11.4% |
| Q1 2020 | $41,128,000 | +38700.0% | 1,308,570 | +58084.5% | 0.04% | – |
| Q4 2019 | $106,000 | +960.0% | 2,249 | +46.7% | 0.00% | – |
| Q3 2019 | $10,000 | -99.0% | 1,533 | -98.9% | 0.00% | -100.0% |
| Q3 2018 | $957,000 | – | 142,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |